These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 38306980)

  • 1. De novo protein design-From new structures to programmable functions.
    Kortemme T
    Cell; 2024 Feb; 187(3):526-544. PubMed ID: 38306980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generative artificial intelligence for de novo protein design.
    Winnifrith A; Outeiral C; Hie BL
    Curr Opin Struct Biol; 2024 Jun; 86():102794. PubMed ID: 38663170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Design of Polyhedral Protein Assemblies: Before and After the AI Revolution.
    Mallik BB; Stanislaw J; Alawathurage TM; Khmelinskaia A
    Chembiochem; 2023 Aug; 24(15):e202300117. PubMed ID: 37014094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence in
    Kumar R; Sharma A; Alexiou A; Ashraf GM
    Curr Top Med Chem; 2022; 22(30):2483-2492. PubMed ID: 36263480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation.
    Tang X; Dai H; Knight E; Wu F; Li Y; Li T; Gerstein M
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 39007594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AlphaFold accurately predicts distinct conformations based on the oligomeric state of a de novo designed protein.
    Cummins MC; Jacobs TM; Teets FD; DiMaio F; Tripathy A; Kuhlman B
    Protein Sci; 2022 Jul; 31(7):e4368. PubMed ID: 35762713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Drug Discovery with Deep Learning.
    Özçelik R; van Tilborg D; Jiménez-Luna J; Grisoni F
    Chembiochem; 2023 Jul; 24(13):e202200776. PubMed ID: 37014633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Progress of Deep Learning in Drug Discovery.
    Wang F; Diao X; Chang S; Xu L
    Curr Pharm Des; 2021; 27(17):2088-2096. PubMed ID: 33511933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Brief History of De Novo Protein Design: Minimal, Rational, and Computational.
    Woolfson DN
    J Mol Biol; 2021 Oct; 433(20):167160. PubMed ID: 34298061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence-Enabled De Novo Design of Novel Compounds that Are Synthesizable.
    Bhisetti G; Fang C
    Methods Mol Biol; 2022; 2390():409-419. PubMed ID: 34731479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has Drug Design Augmented by Artificial Intelligence Become a Reality?
    Chen H; Engkvist O
    Trends Pharmacol Sci; 2019 Nov; 40(11):806-809. PubMed ID: 31629547
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Korendovych IV; DeGrado WF
    Q Rev Biophys; 2020 Feb; 53():e3. PubMed ID: 32041676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Science Meets Artificial Intelligence: A Systematic Review and a Biochemical Meta-Analysis of an Inter-Field.
    Villalobos-Alva J; Ochoa-Toledo L; Villalobos-Alva MJ; Aliseda A; Pérez-Escamirosa F; Altamirano-Bustamante NF; Ochoa-Fernández F; Zamora-Solís R; Villalobos-Alva S; Revilla-Monsalve C; Kemper-Valverde N; Altamirano-Bustamante MM
    Front Bioeng Biotechnol; 2022; 10():788300. PubMed ID: 35875501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating metals into de novo proteins.
    Peacock AF
    Curr Opin Chem Biol; 2013 Dec; 17(6):934-9. PubMed ID: 24183813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
    Muller C; Rabal O; Diaz Gonzalez C
    Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.
    Lin E; Lin CH; Lane HY
    J Chem Inf Model; 2022 Feb; 62(4):761-774. PubMed ID: 35128926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence and machine learning in design of mechanical materials.
    Guo K; Yang Z; Yu CH; Buehler MJ
    Mater Horiz; 2021 Apr; 8(4):1153-1172. PubMed ID: 34821909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards functional de novo designed proteins.
    Dawson WM; Rhys GG; Woolfson DN
    Curr Opin Chem Biol; 2019 Oct; 52():102-111. PubMed ID: 31336332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.